Status:

RECRUITING

Promoting Alcohol Treatment Engagement Post-hospitalization

Lead Sponsor:

Yale University

Collaborating Sponsors:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Conditions:

Alcohol Use Disorder

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study is a 3-arm randomized clinical trial to evaluate the effectiveness of hospital-initiated Alcohol Use Disorder treatment, involving a Brief Negotiated Interview (with referral and telephone ...

Detailed Description

The proposed 3-arm randomized clinical trial will initiate interventions during hospitalization and evaluate outcomes at 34- and 90-days following hospital discharge to compare the effectiveness of 1)...

Eligibility Criteria

Inclusion

  • hospitalized at Yale New Haven Hospital (YNHH)
  • meet Diagnostic and Statistical Manual (DSM-5) criteria for a moderate to severe AUD (regardless of primary reason for hospitalization) consistent with clinical guidelines for MAUD initiation
  • \>1 heavy drinking day by TLFB in 30 days prior to hospitalization
  • willing to consider MAUD
  • willing and able to be contacted for follow-up
  • provide written informed consent

Exclusion

  • have been engaged in formal AUD treatment in the past 30 days (i.e., excluding mutual help groups, such as Alcoholics Anonymous)
  • meet DSM-5 criteria for untreated moderate to severe opioid use disorder
  • self-reported or urine testing confirming pregnancy, nursing, or trying to conceive
  • life-threatening or unstable medical, surgical, or psychiatric condition that prohibits study participation
  • inability to provide \>1 collateral contact for a friend or family member
  • anticipate being unable to return for follow-up assessments for any reason, such as travel, incarceration, planned procedure
  • inability to understand English or Spanish.

Key Trial Info

Start Date :

September 13 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2026

Estimated Enrollment :

450 Patients enrolled

Trial Details

Trial ID

NCT05338151

Start Date

September 13 2022

End Date

December 31 2026

Last Update

April 25 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Yale New Haven Hospital

New Haven, Connecticut, United States, 06510